Successful treatment of idiopathic hypereosinophilic syndrome with benralizumab in a pediatric patient

J Allergy Clin Immunol Pract. 2021 Jan;9(1):589-590. doi: 10.1016/j.jaip.2020.08.034. Epub 2020 Sep 1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Child
  • Humans
  • Hypereosinophilic Syndrome* / diagnosis
  • Hypereosinophilic Syndrome* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • benralizumab